ELAN - Elanco Animal Health Incorporated

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 511.89B
Enterprise Value 314.16B
Trailing P/E 237.23
Forward P/E 125.39
PEG Ratio (5 yr expected) 12.36
Price/Sales (ttm)3.88
Price/Book (mrq)2.29
Enterprise Value/Revenue 34.62
Enterprise Value/EBITDA 621.18

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 36.70%
52 Week High 337.61
52 Week Low 328.00
50-Day Moving Average 333.22
200-Day Moving Average 331.84

Share Statistics

Avg Vol (3 month) 33.07M
Avg Vol (10 day) 32.09M
Shares Outstanding 5N/A
Float 365.56M
% Held by Insiders 10.19%
% Held by Institutions 135.45%
Shares Short (Jun 28, 2019) 413.6M
Short Ratio (Jun 28, 2019) 44.68
Short % of Float (Jun 28, 2019) 43.72%
Short % of Shares Outstanding (Jun 28, 2019) 43.72%
Shares Short (prior month May 31, 2019) 416.05M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 1.48%
Operating Margin (ttm)11.88%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)0.70%

Income Statement

Revenue (ttm)3.06B
Revenue Per Share (ttm)9.23
Quarterly Revenue Growth (yoy)-0.70%
Gross Profit (ttm)1.53B
EBITDA 668.5M
Net Income Avi to Common (ttm)45.3M
Diluted EPS (ttm)0.14
Quarterly Earnings Growth (yoy)-56.70%

Balance Sheet

Total Cash (mrq)272.1M
Total Cash Per Share (mrq)0.74
Total Debt (mrq)2.55B
Total Debt/Equity (mrq)49.01
Current Ratio (mrq)3.22
Book Value Per Share (mrq)14.21

Cash Flow Statement

Operating Cash Flow (ttm)445.9M
Levered Free Cash Flow (ttm)N/A